ASIA-PACIFIC NASAL SPRAY MARKET 2021-2028

 

 TABLE OF CONTENTS

 

1.     ASIA-PACIFIC NASAL SPRAY MARKET - SUMMARY

2.     INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON NASAL SPRAY MARKET

2.2. KEY INSIGHTS

2.2.1.    ALLERGY TREATMENTS WITH NASAL SPRAYS

2.2.2.    UTILIZING NASAL SPRAY FOR DIABETES

2.2.3.    ENDOMETRIOSIS TREATMENT WITH NASAL SPRAYS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.    THREAT OF NEW ENTRANTS

2.3.2.    THREAT OF SUBSTITUTES

2.3.3.    BARGAINING POWER OF BUYERS

2.3.4.    BARGAINING POWER OF SUPPLIERS

2.3.5.    THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY MARKET STRATEGIES

2.6.1.    MERGERS & ACQUISITIONS

2.6.2.    CONTRACTS & AGREEMENTS

2.6.3.    DIVESTITURES

2.7. MARKET DRIVERS

2.7.1.    EMERGING INTRANASAL VACCINES FOR COVID-19

2.7.2.    INCREASING ACCEPTANCE OF SELF-ADMINISTRATION OF MEDICATION

2.7.3.    GROWING USE OF NASAL SPRAYS DUE TO SIMPLE ADMINISTRATION TECHNIQUES

2.8. MARKET CHALLENGES

2.8.1.    COMPLICATIONS DUE TO EXCESS USE OF NASAL SPRAYS

2.9. MARKET OPPORTUNITIES

2.9.1.    APPLICATION OF NASAL SPRAYS IN TREATING DEPRESSION

2.9.2.    USING INTRANASAL TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS

2.9.3.    EMPLOYING NASAL SPRAY AS A VACCINE

3.     ASIA-PACIFIC NASAL SPRAY MARKET OUTLOOK - BY TYPE

3.1. DECONGESTION NASAL SPRAY

3.2. STEROID NASAL SPRAY

3.3. SALTWATER SOLUTION/SALINE NASAL SPRAY

4.     ASIA-PACIFIC NASAL SPRAY MARKET OUTLOOK - BY PRESCRIPTION

4.1. OVER-THE-COUNTER

4.2. PRESCRIBED

5.     ASIA-PACIFIC NASAL SPRAY MARKET OUTLOOK - BY THERAPEUTIC

5.1. ANTIHISTAMINE

5.2. NASAL STEROIDS

5.3. ANTICHOLINERGIC

5.4. MAST CELL INHIBITOR

6.     ASIA-PACIFIC NASAL SPRAY MARKET OUTLOOK - BY APPLICATION

6.1. NASAL CONGESTION

6.2. ALLERGIC AND NON-ALLERGIC RHINITIS

6.3. VACCINATION

6.4. CNS DISORDERS

6.5. OTHER APPLICATIONS

7.     ASIA-PACIFIC NASAL SPRAY MARKET OUTLOOK - BY END-USER

7.1. HOME CARE SETTING

7.2. ASC/CLINICS

7.3. PHARMACY

7.4. HOSPITAL

7.5. OTHER END-USERS

8.     ASIA-PACIFIC NASAL SPRAY MARKET – REGIONAL OUTLOOK

8.1. CHINA

8.2. JAPAN

8.3. INDIA

8.4. SOUTH KOREA

8.5. ASEAN COUNTRIES

8.6. AUSTRALIA & NEW ZEALAND

8.7. REST OF ASIA-PACIFIC

9.     COMPETITIVE LANDSCAPE

9.1. AKORN

9.2. ALLERGAN

9.3. APOTEX INC

9.4. BHARAT BIOTECH

9.5. CATALENT INC

9.6. CIPLA LIMITED

9.7. GLAXOSMITHKLINE

9.8. JOHNSON AND JOHNSON

9.9. NOVARTIS INTERNATIONAL AG

9.10.               PFIZER INC

9.11.               PROCTOR AND GAMBLE CO

9.12.               SANOTIZE RESEARCH AND DEVELOPMENT

9.13.               SUN PHARMACEUTICALS INDUSTRIES LTD

9.14.               TEVA PHARMACEUTICAL INDUSTRIES LTD

9.15.               VIATRIS

10. RESEARCH METHODOLOGY & SCOPE

10.1.               RESEARCH SCOPE & DELIVERABLES

10.2.               SOURCES OF DATA

10.3.               RESEARCH METHODOLOGY

 

 

TABLE LIST

TABLE 1: ASIA-PACIFIC NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: ASIA-PACIFIC NASAL SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 4: ASIA-PACIFIC NASAL SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)

TABLE 5: ASIA-PACIFIC NASAL SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)

TABLE 6: ASIA-PACIFIC NASAL SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 7: ASIA-PACIFIC NASAL SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 8: ASIA-PACIFIC NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

 

 

FIGURE LIST

 

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: ASIA-PACIFIC NASAL SPRAY MARKET, BY TYPE, 2020 & 2028 (IN %)

FIGURE 3: ASIA-PACIFIC NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 4: ASIA-PACIFIC NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 5: ASIA-PACIFIC NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 6: ASIA-PACIFIC NASAL SPRAY MARKET, BY PRESCRIPTION, 2020 & 2028 (IN %)

FIGURE 7: ASIA-PACIFIC NASAL SPRAY MARKET, BY OVER-THE-COUNTER, 2021-2028 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC NASAL SPRAY MARKET, BY THERAPEUTIC, 2020 & 2028 (IN %)

FIGURE 10: ASIA-PACIFIC NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC NASAL SPRAY MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 15: ASIA-PACIFIC NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS, 2021-2028 (IN $ MILLION)

FIGURE 17: ASIA-PACIFIC NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 19: ASIA-PACIFIC NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 20: ASIA-PACIFIC NASAL SPRAY MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 21: ASIA-PACIFIC NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $ MILLION)

FIGURE 22: ASIA-PACIFIC NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 23: ASIA-PACIFIC NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)

FIGURE 24: ASIA-PACIFIC NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)

FIGURE 25: ASIA-PACIFIC NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 26: ASIA-PACIFIC NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 27: CHINA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 28: JAPAN NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 29: INDIA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 30: SOUTH KOREA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 31: ASEAN COUNTRIES NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 32: AUSTRALIA & NEW ZEALAND NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 33: REST OF ASIA-PACIFIC NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

 

 

MARKET OUTLOOK

 

Triton’s report on the Asia-Pacific nasal spray market suggests that the market is likely to advance at a CAGR of 9.24% during the expected phase 2021-2028. South Korea, India, Australia & New Zealand, ASEAN countries, China, Japan, and Rest of APAC outline the overall market in the given region.

Allergic rhinitis is highly prevalent among the younger population in Japan. As per the International Study of Asthma and Allergies in Childhood, the occurrence of allergic rhinitis is at a medium level in the country. Moreover, with the growing geriatric population, patients suffering from pneumonia, respiratory failure, lung cancer, and asthma have increased. Furthermore, the number of deaths due to air pollution increased in 2019. As a result, this rise in respiratory conditions has increased the demand for nasal sprays across the country. Thus, these factors support the overall growth of the Japanese nasal spray market.

Likewise, chronic rhinosinusitis is a common condition experienced by a large population base in India. Besides, approximately 20-30% of people suffer from allergic rhinitis. Further, chronic respiratory diseases, especially asthma, and chronic obstructive pulmonary diseases, are major conditions that have increased the mortality rate across the country. Additionally, the rising population has resulted in the increased use of private cars, construction of new homes, and development of public infrastructure, increasing the population levels significantly. As a result, these factors are estimated to widen the adoption of nasal sprays, simultaneously boosting the Indian nasal spray market.

 

 

COMPETITIVE OUTLOOK

 

The distinguished companies thriving in the nasal spray market include Sun Pharmaceuticals Industries Ltd, Bharat Biotech, GlaxoSmithKline, Novartis International AG, Allergan, Cipla Limited, and Viatris.

 

Get more insights into the Asia-Pacific Nasal Spray Market:

 

https://www.tritonmarketresearch.com/reports/asia-pacific-nasal-spray-market

 

 

SEGMENTATION

 

1.     AKORN

2.     ALLERGAN

3.     APOTEX INC

4.     BHARAT BIOTECH

5.     CATALENT INC

6.     CIPLA LIMITED

7.     GLAXOSMITHKLINE

8.     JOHNSON AND JOHNSON

9.     NOVARTIS INTERNATIONAL AG

10. PFIZER INC

11. PROCTOR AND GAMBLE CO

12. SANOTIZE RESEARCH AND DEVELOPMENT

13. SUN PHARMACEUTICALS INDUSTRIES LTD

14. TEVA PHARMACEUTICAL INDUSTRIES LTD

15. VIATRIS